Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Endometrial Cancer, Endometrial Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07595224
What this trial is testing

Postoperative Hypofractionated Whole Pelvic Radiotherapy in Cervical and Endometrial Cancer

Who this might be right for
Endometrial CancerCervix Cancer
Siriraj Hospital 120
Early research (Phase 1)Study completedNCT00315861
What this trial is testing

Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies

Who this might be right for
Ovarian CancerEndometrial CancerCervical Cancer+1 more
SCRI Development Innovations, LLC 15
Early research (Phase 1)Active Not RecruitingNCT07038369
What this trial is testing

ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

Who this might be right for
Advanced Solid TumorsBreast CancerBreast Carcinoma+24 more
Atavistik Bio, Inc 134
Testing effectiveness (Phase 2)Study completedNCT03192059
What this trial is testing

Study of Pembrolizumab, Radiation and Immune Modulatory Cocktail in Cervical/Uterine Cancer

Who this might be right for
Cervical CancerEndometrial CancerUterine Cancer
University Hospital, Ghent 43
Not applicableStudy completedNCT02093546
What this trial is testing

Biospecimen Collection in Assessing the Effect of Trametinib With or Without Uprosertib on Biomarkers in Patients With Persistent or Recurrent Endometrial Cancer Enrolled on Trial GOG02290

Who this might be right for
Recurrent Endometrial Carcinoma
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT05682950
What this trial is testing

Optimal Margin Evaluation of Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer

Who this might be right for
Uterine Cervical NeoplasmEndometrial Neoplasms
Peking Union Medical College Hospital 15
Testing effectiveness (Phase 2)Looking for participantsNCT07108270
What this trial is testing

Dostarlimab in Combination With Carboplatin-paclitaxel in Chinese Participants With Primary Advanced or Recurrent Endometrial Cancer (EC)

Who this might be right for
Neoplasms, Endometrial
GlaxoSmithKline 30
Testing effectiveness (Phase 2)Study completedNCT00019331
What this trial is testing

Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors

Who this might be right for
Colorectal CancerEndometrial CancerHead and Neck Cancer+6 more
National Cancer Institute (NCI)
Not applicableUnknownNCT03366051
What this trial is testing

Sentinel Node Mapping in High Risk Endometrial Cancer

Who this might be right for
Endometrial CancerLymph Node Metastases
AC Camargo Cancer Center 178
Early research (Phase 1)Ended earlyNCT06714617
What this trial is testing

Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors

Who this might be right for
Breast Cancer Stage IIIHER2-positive Metastatic Breast CancerUnresectable Breast Carcinoma+11 more
SystImmune Inc. 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 798
Large-scale testing (Phase 3)Looking for participantsNCT06379113
What this trial is testing

GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients

Who this might be right for
Endometrial NeoplasmsAtypical Endometrial HyperplasiaProgesterone Resistance+1 more
Xiaojun Chen 29
Testing effectiveness (Phase 2)Study completedNCT00910091
What this trial is testing

The Study of Oral Steroid Sulphatase Inhibitor BN83495 Versus Megestrol Acetate (MA) in Women With Advanced or Recurrent Endometrial Cancer

Who this might be right for
Endometrial Cancer
Ipsen 73
Not applicableStudy completedNCT00340210
What this trial is testing

Extended Follow-up of Columbia, MO Serum Bank Participants

Who this might be right for
Breast CancerEndometrial CancerOvarian Cancer
National Cancer Institute (NCI) 6,720
Not applicableActive Not RecruitingNCT01977274
What this trial is testing

Predictive Clinical and Biological Parameters in Gynecological Cancer

Who this might be right for
Ovarian CancerEndometrium CancerCervix Cancer
Institut Paoli-Calmettes 300
Not applicableStudy completedNCT05796518
What this trial is testing

Feasibility of a Patient Directed Tool to Assess Heart Health Among Endometrial Cancer Survivors

Who this might be right for
Endometrial CancerSurvivorship
Wake Forest University Health Sciences 44
Very early researchLooking for participantsNCT05691010
What this trial is testing

Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer

Who this might be right for
Endometrial CancerStage III Endometrial CancerStage III Endometrial Carcinoma+2 more
Memorial Sloan Kettering Cancer Center 28
Large-scale testing (Phase 3)Ended earlyNCT00577317
What this trial is testing

Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer

Who this might be right for
LymphedemaStage 0 Cervical CancerStage 0 Uterine Corpus Cancer+16 more
Gynecologic Oncology Group 2
Testing effectiveness (Phase 2)Ended earlyNCT00470067
What this trial is testing

Doxorubicin Hydrochloride Liposome and Carboplatin in Treating Patients With Recurrent, Stage III, or Stage IV Primary Endometrial Cancer

Who this might be right for
Endometrial Cancer
Roswell Park Cancer Institute 9
Testing effectiveness (Phase 2)Ended earlyNCT04527900
What this trial is testing

The UPPROACH (Upfront Intensity Modulated Proton Beam Therapy) Approach

Who this might be right for
Endometrial Cancer
University of Maryland, Baltimore 2
Next Page